Agency Forms Undergoing Paperwork Reduction Act Review, 34158-34159 [2023-11266]
Download as PDF
34158
Federal Register / Vol. 88, No. 102 / Friday, May 26, 2023 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–11264 Filed 5–25–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–23AP]
ddrumheller on DSK120RN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘TRANSCEND:
Transgender status-neutral communityto-clinic models to end the HIV
epidemic’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on November
16, 2022 to obtain comments from the
public and affected agencies. CDC
received three comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
VerDate Sep<11>2014
18:14 May 25, 2023
Jkt 259001
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
TRANSCEND: Transgender statusneutral community-to-clinic models to
end the HIV epidemic—New—National
Center for HIV, Viral Hepatitis, STD, TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC requesting public comment
and OMB approval on a New
information collection request (ICR) for
the demonstration project titled
‘‘TRANSCEND: Transgender statusneutral community-to-clinic models to
end the HIV epidemic.’’
Transgender (TG) persons, especially
transgender women (TGW), have a high
prevalence of HIV and lifetime risk of
acquiring HIV. In the 2019–2020
National HIV Behavioral Surveillance
Trans cycle, 42% of TGW tested
positive for HIV. Racial/ethnic
disparities were also found, with HIV
positivity rates of 62% among Black/
African American TGW and 35% among
Hispanic/Latina TGW compared to 17%
among White TGW. Despite the
disproportionate burden of HIV among
TGW, receipt of HIV prevention and
care services have been suboptimal.
Many TG persons experience poverty,
homelessness, abuse, and have
substance use or mental health
disorders, which impact access to and
utilization of HIV prevention and care
services. Many TG persons seek genderaffirming care, including hormone
therapy, at transgender health care
organizations (TG clinics), and these
encounters provide opportunities for
HIV testing and status-neutral HIV
services.
In the proposed demonstration
project, TG clinics and transgender-
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
serving community-based organizations
(CBOs) will work collaboratively to
evaluate community-to-clinic models to
provide integrated status-neutral HIV
prevention and care services, genderaffirming services including hormone
therapy, and primary healthcare, as well
as to ensure access to mental health,
substance use, and social support
services. All services will be culturally
and linguistically responsive for TG
persons to ensure that they feel
welcomed, heard, and cared for. The
recipients will also participate in a
national learning collaborative to share
lessons learned and best practices for
TG clinic and TG CBO partnerships to
provide status-neutral, community-toclinic services for TG persons.
This collection of data, which
involves creation of a unique identifier
so that CDC does not receive any
personally identifiable information (PII),
will allow CDC to assist TG clinics and
CBOs in monitoring and evaluating their
programs providing status-neutral HIV
services and comprehensive healthcare
for TG persons and for community-toclinic models of service provision.
Longitudinal person-level data
collection will occur through the
clinics’ electronic health record (EHR
Data Form) and the Client Intake Form,
and additional program evaluation data
will be collected through client surveys
(Client Satisfaction Survey).
The clients will complete the Client
Intake Form once when they first join
the program, with expected 800 clients
per year for a total burden of 107 hours
annually. A sample of 100 clients per
site (400 total) will respond to the Client
Satisfaction Survey once per year, for a
total burden of 100 hours annually. The
four data managers will extract data
from the EHR, perform quality checks,
code the data with a unique identifier,
and transmit the deidentified data to
CDC two times per year, for a total of 64
hours per year. The four data managers
will also compile, link, deidentify, and
report data from the Client Intake Forms
two times per year, with an estimated
burden of 16 hours annually. The four
data managers will compile and report
data from the Satisfaction Survey once
per year, with an estimated burden of
eight hours annually.
OMB approval is requested for three
years. Participation of the funded
recipients’ data managers is required,
and participation from the clients is
voluntary. There is no cost to
participants other than their time. The
total estimated annualized burden is
295 hours.
E:\FR\FM\26MYN1.SGM
26MYN1
34159
Federal Register / Vol. 88, No. 102 / Friday, May 26, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
TRANSCEND
TRANSCEND
TRANSCEND
TRANSCEND
TRANSCEND
Number of
respondents
Form name
Recipient Data Manager .........
Recipient Data Manager .........
Clients ......................................
Clients ......................................
Recipient Data Manager .........
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–11266 Filed 5–25–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Electronic Health Record Data Form .............
Client Intake Form ..........................................
Client Intake Form ..........................................
Client Satisfaction Survey ..............................
Client Satisfaction Survey ..............................
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2023–11326 Filed 5–25–23; 8:45 am]
World Trade Center Health Program
Scientific/Technical Advisory
Committee; Notice of Charter Renewal
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of charter renewal.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), announces the renewal
of the charter of the World Trade Center
(WTC) Health Program Scientific/
Technical Advisory Committee (STAC).
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D., M.S.,
Designated Federal Officer, World Trade
Center Health Program Scientific/
Technical Advisory Committee,
National Institute for Occupational
Safety and Health, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop R–12, Atlanta,
Georgia 30329–4027. Telephone: (513)
841–4515; Email: TCarreonValencia@
cdc.gov.
SUMMARY:
CDC is
providing notice under 5 U.S.C. 1001–
1014 of the renewal of the charter of the
WTC Health Program STAC. The STAC
was established by title I of Public Law
111–347 (the James Zadroga 9/11 Health
and Compensation Act of 2010), as
amended by Public Laws 114–113, 116–
59, and 117–328. This charter has been
renewed for a two-year period through
May 12, 2025.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
ddrumheller on DSK120RN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
18:14 May 25, 2023
Jkt 259001
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2023–0040; NIOSH
248–K]
World Trade Center Health Program
Scientific/Technical Advisory
Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP–STAC). This
virtual meeting is open to the public.
Time will be available for public
comment.
SUMMARY:
The meeting will be held on June
21, 2023, from 11 a.m. to 4 p.m., EDT,
and June 22, 2023, from 11 a.m. to 1:30
p.m., EDT.
Written public comments must be
received by June 22, 2023. Members of
the public who wish to address the
WTCHP–STAC during the oral public
comment session must sign up to speak
by June 14, 2023, at the email address
DATES:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
4
4
800
400
4
2
2
1
1
1
Average
burden per
response
(in hours)
8
2
8/60
15/60
2
provided in the Procedure for Oral
Public Comment section below.
ADDRESSES: This is a virtual meeting
conducted via Zoom. The public is
welcome to follow the proceedings via
live webcast at the following link:
https://www.ustream.tv/channel/
QyXBRzYjVCS. No registration is
required. For additional information,
please visit the World Trade Center
Health Program website at https://
www.cdc.gov/wtc/stac_meeting.html.
You may submit comments, identified
by Docket No. CDC–2023–0040; NIOSH
248–K by either of the methods listed
below. CDC does not accept comments
by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Ms. Sherri Diana, NIOSH
Docket Office, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1090 Tusculum Avenue, Mailstop C–34,
Cincinnati, Ohio 45226. Attn: Docket
No. CDC–2023–0040; NIOSH 248–K.
Instructions: All submissions received
must include the Agency name and
docket number (CDC–2023–0040;
NIOSH 248–K). The docket will close on
June 22, 2023. All relevant comments,
including any personal information
provided, will be posted without change
to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D., M.S.,
Designated Federal Officer, World Trade
Center Health Program Scientific/
Technical Advisory Committee,
National Institute for Occupational
Safety and Health, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop R–12, Atlanta,
Georgia 30329–4027. Telephone: (513)
841–4515; Email: wtc-stac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The World Trade Center
(WTC) Health Program, including the
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP–STAC), was
established by Title I of the James
Zadroga 9/11 Health and Compensation
Act of 2010, Public Law 111–347, as
E:\FR\FM\26MYN1.SGM
26MYN1
Agencies
[Federal Register Volume 88, Number 102 (Friday, May 26, 2023)]
[Notices]
[Pages 34158-34159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11266]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-23-23AP]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``TRANSCEND: Transgender status-neutral
community-to-clinic models to end the HIV epidemic'' to the Office of
Management and Budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on November 16, 2022 to obtain comments from
the public and affected agencies. CDC received three comments related
to the previous notice. This notice serves to allow an additional 30
days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
TRANSCEND: Transgender status-neutral community-to-clinic models to
end the HIV epidemic--New--National Center for HIV, Viral Hepatitis,
STD, TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The CDC requesting public comment and OMB approval on a New
information collection request (ICR) for the demonstration project
titled ``TRANSCEND: Transgender status-neutral community-to-clinic
models to end the HIV epidemic.''
Transgender (TG) persons, especially transgender women (TGW), have
a high prevalence of HIV and lifetime risk of acquiring HIV. In the
2019-2020 National HIV Behavioral Surveillance Trans cycle, 42% of TGW
tested positive for HIV. Racial/ethnic disparities were also found,
with HIV positivity rates of 62% among Black/African American TGW and
35% among Hispanic/Latina TGW compared to 17% among White TGW. Despite
the disproportionate burden of HIV among TGW, receipt of HIV prevention
and care services have been suboptimal. Many TG persons experience
poverty, homelessness, abuse, and have substance use or mental health
disorders, which impact access to and utilization of HIV prevention and
care services. Many TG persons seek gender-affirming care, including
hormone therapy, at transgender health care organizations (TG clinics),
and these encounters provide opportunities for HIV testing and status-
neutral HIV services.
In the proposed demonstration project, TG clinics and transgender-
serving community-based organizations (CBOs) will work collaboratively
to evaluate community-to-clinic models to provide integrated status-
neutral HIV prevention and care services, gender-affirming services
including hormone therapy, and primary healthcare, as well as to ensure
access to mental health, substance use, and social support services.
All services will be culturally and linguistically responsive for TG
persons to ensure that they feel welcomed, heard, and cared for. The
recipients will also participate in a national learning collaborative
to share lessons learned and best practices for TG clinic and TG CBO
partnerships to provide status-neutral, community-to-clinic services
for TG persons.
This collection of data, which involves creation of a unique
identifier so that CDC does not receive any personally identifiable
information (PII), will allow CDC to assist TG clinics and CBOs in
monitoring and evaluating their programs providing status-neutral HIV
services and comprehensive healthcare for TG persons and for community-
to-clinic models of service provision. Longitudinal person-level data
collection will occur through the clinics' electronic health record
(EHR Data Form) and the Client Intake Form, and additional program
evaluation data will be collected through client surveys (Client
Satisfaction Survey).
The clients will complete the Client Intake Form once when they
first join the program, with expected 800 clients per year for a total
burden of 107 hours annually. A sample of 100 clients per site (400
total) will respond to the Client Satisfaction Survey once per year,
for a total burden of 100 hours annually. The four data managers will
extract data from the EHR, perform quality checks, code the data with a
unique identifier, and transmit the deidentified data to CDC two times
per year, for a total of 64 hours per year. The four data managers will
also compile, link, deidentify, and report data from the Client Intake
Forms two times per year, with an estimated burden of 16 hours
annually. The four data managers will compile and report data from the
Satisfaction Survey once per year, with an estimated burden of eight
hours annually.
OMB approval is requested for three years. Participation of the
funded recipients' data managers is required, and participation from
the clients is voluntary. There is no cost to participants other than
their time. The total estimated annualized burden is 295 hours.
[[Page 34159]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
TRANSCEND Recipient Data Manager...... Electronic Health Record 4 2 8
Data Form.
TRANSCEND Recipient Data Manager...... Client Intake Form...... 4 2 2
TRANSCEND Clients..................... Client Intake Form...... 800 1 8/60
TRANSCEND Clients..................... Client Satisfaction 400 1 15/60
Survey.
TRANSCEND Recipient Data Manager...... Client Satisfaction 4 1 2
Survey.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-11266 Filed 5-25-23; 8:45 am]
BILLING CODE 4163-18-P